Globally, these results indicate that increased expression of those EMT-related genes occurs along tumor progression, which is further underscored by the finding of increased CAMK2N1 and WNT5A immunoexpression in metastatic PCa. This evidence concerns the gene CAMK2N1 and neoplasm.